Oral corticosteroids

Pipeline

Status by Indication[2][1]

Competition

Competitive Landscape

8 competitors in Dermatitis, Atopic

#DrugCompanyPhaseTrials

1

Amlitelimab

Sanofi

Phase 3

72

Topical Corticosteroids

Sanofi

Phase 3

33

Topical Calcineurin Inhibitors

Sanofi

Phase 3

24

JNJ-95597528

Johnson & Johnson

Phase 2

15

Calcineurin Inhibitors

Sanofi

Preclinical

26

Oral corticosteroids

Sanofi

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

OTC Deficiency1 trial

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adeno-associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Patients With Late-onset OTC Deficiency

Active, not recruiting·Ultragenyx·Phase 3·NCT05345171·37 enrolled

Dermatitis, Atopic1 trial

A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants of Previous Amlitelimab Clinical Trials in Moderate to Severe Atopic Dermatitis.

Active, not recruiting·Sanofi·Preclinical·NCT05492578·1,856 enrolled

Details

Drug Info

Related News